Revolution Medicines, Inc. (FRA:42Z)
Germany · Delayed Price · Currency is EUR 67.50
-1.50 (-2.17%)
At close: Dec 30, 2025
Revolution Medicines Market Cap
Revolution Medicines has a market cap or net worth of €19.72 billion as of January 9, 2026. Its market cap has increased by 152.53% in one year.
Market Cap
19.72B
Enterprise Value
18.41B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
€67.50
Market Cap Chart
Since February 13, 2020, Revolution Medicines's market cap has increased from 1.52B to 19.72B, an increase of 1,201.16%. That is a compound annual growth rate of 54.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 19.72B | 50.35% |
| Dec 31, 2025 | 13.11B | 67.98% |
| Dec 31, 2024 | 7.81B | 82.84% |
| Dec 29, 2023 | 4.27B | 115.76% |
| Dec 30, 2022 | 1.98B | 21.35% |
| Dec 31, 2021 | 1.63B | -24.09% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Feb 13, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 247.30B |
| Siemens Aktiengesellschaft | 197.59B |
| Allianz SE | 145.37B |
| Deutsche Telekom AG | 134.99B |
| Siemens Energy AG | 107.65B |
| Rheinmetall AG | 87.17B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 67.47B |
| Deutsche Bank Aktiengesellschaft | 63.02B |